Singleron announced their participation in the upcoming 64th ASH Annual Meeting & Exposition

Singleron Biotechnologies GmbH, a pioneer in development and commercialization of innovative single cell sequencing analysis solutions for precision medicine, announced today their participation in the upcoming 64th American Society of Hematology (ASH) Annual Meeting & Exposition in New Orleans.

Learn More 2022-11-14

GEXSCOPE Single Cell RNA-seq data are now available on Illumina BaseSpace Sequence Hub

Singleron’s GEXSCOPE Single Cell RNA-seq data are now available on Illumina BaseSpace Sequence Hub!

Learn More 2022-11-11

Singleron opens a new state-of-the-art laboratory to showcase the latest single cell sequencing technology

New facility in Cologne, Germany will serve as a laboratory dedicated to R&D and providing demonstrations on the latest innovative technology for single cell sequencing.

Learn More 2022-11-07

First commercial kit to quantify protein modification in single cells

Singleron announces the launch of ProMoSCOPE, the first commercially available kit to quantify protein glycosylation at single cell level

Learn More 2022-11-03

Singleron supports Project Maleth’s second mission MALETH II

Maleth Program is the first space bioscience project led by Professor Joseph Borg of the University of Malta.

Learn More 2022-07-12

Proteona opens new laboratory in Singapore

New facility will serve as regional headquarters for Singleron in Asia

Learn More 2022-05-11

Singleron Acquires Proteona

Singleron further extends reach outside China and strengthens its expertise in translational and clinical research

Learn More 2022-03-07

Singleron Completes Series B Financing

Singleron Biotechnologies recently completed its oversubscribed Series B financing, raising close to $100M.

Learn More 2021-11-08

Webinar invitation: Singleron PythoN™ Automated Tissue Dissociation System

Join our free webinar to get to know our new fully automated tissue dissociation system!

Learn More 2021-09-09

GenomeWeb Reports on Singleron’s Efforts in Bringing Single Cell Technologies to Clinics

Genomeweb article titled “China's Singleron Biotechnologies Pushes Single-Cell RNA-seq Into Clinical, Translational Studies”

Learn More 2021-08-03

Singleron Completes Series A2 Financing, Raising Close to $30M

Singleron has raised in A, A1, A2 about $70M in total and introduced prominent investors such as LAV, CDH, ARCH Venture Partners, CDG Capital, and Tencent as new shareholders of the company. 

Learn More 2021-06-24

Singleron products used in breakthrough COVID-19 study

Singleron' products were used in a Covid-study which was recently published in Cell Research on June 16, 2021

Learn More 2021-06-21

Singleron partnered with XtalPi, launching AI Drug Discovery Collaboration

Singleron Biotechnologies announced a drug discovery partnership with XtalPi Inc., an AI-powered pharmaceutical technology company.

Learn More 2021-03-04

Agilent Technologies and Singleron to Collaborate on Single Cell Sequencing

Singleron Biotechnologies announced its collaboration with Agilent Technologies Inc. (NYSE: A) to accelerate the development and application of single cell sequencing technology.

Learn More 2021-01-28

Singleron Completes Series A1 Financing, Raising More Than $10M

Singleron completed Series A1 financing of more than $10M, following a recent Series A round that raised $30M

Learn More 2020-11-09

Singleron Completes $30 Million Series A Financing

Singleron announced the successful completion of $30 million Series A financing led by Lilly Asia Ventures (LAV)

Learn More 2020-09-10

Berry Genomics and Singleron Biotechnologies moved into strategic alliance

Learn More 2020-08-21

Singleron’s technology used in Wuhan to help fight against the COVID-19

Report from Wuhan Huoshenshan Hospital to fight against Covid-19

Learn More 2020-03-22

Yale Spinout, Singleron Biotechnologies, Secures a Pre-Series A Financing for $10M

Singleron technologies secured a pre-series A financing worth more than $10M

Learn More 2019-06-26